Unstable Angina clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • Milvexian in Participants After a Recent Acute Coronary Syndrome

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major adverse cardiovascular event (MACE) (the composite of cardiovascular [CV] death, myocardial infarction [MI], and ischemic stroke).

    San Diego, California and other locations

Last updated: